Matthias Bodenstedt
2022
In 2022, Matthias Bodenstedt earned a total compensation of $5.7M as Chief Financial Officer at MoonLake Immunotherapeutics, a 640% increase compared to previous year.
Compensation breakdown
| Bonus | $243,675 |
|---|---|
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $22,718 |
| Salary | $324,900 |
| Stock Awards | $5,044,225 |
| Other | $19,670 |
| Total | $5,655,188 |
Bodenstedt received $5M in stock awards, accounting for 89% of the total pay in 2022.
Bodenstedt also received $243.7K in bonus, $22.7K of change in pension value and nonqualified deferred compensation earnings, $324.9K in salary and $19.7K in other compensation.
Rankings
In 2022, Matthias Bodenstedt's compensation ranked 546th out of 5,760 executives tracked by ExecPay. In other words, Bodenstedt earned more than 90.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 546 out of 5,760 | 91st |
Division Manufacturing | 230 out of 3,136 | 93rd |
Major group Chemicals And Allied Products | 72 out of 1,422 | 95th |
Industry group Drugs | 60 out of 1,323 | 96th |
Industry Pharmaceutical Preparations | 43 out of 969 | 96th |
Source: SEC filing on April 26, 2023.
Bodenstedt's colleagues
We found two more compensation records of executives who worked with Matthias Bodenstedt at MoonLake Immunotherapeutics in 2022.